Haploid inducer line for accelerated genome editing

Patent metadata

Field	Value
Publication number	US-11845943-B2
Application number	US-202117541109-A
Country	US
Kind code	B2
Filing date	Dec 2, 2021
Priority date	Jun 30, 2015
Publication date	Dec 19, 2023
Grant date	Dec 19, 2023

Abstract

Provided herein are materials and in planta methods for using haploid inducer lines containing a targeted endonuclease to generate transgenic or non-transgenic plants with targeted mutations and/or genomic modifications. Also provided herein.

First claim

What is claimed is:

1. A method for generating a doubled haploid plant cell comprising a transgenic DNA sequence inserted at or near a selected DNA sequence, said method comprising:
(a) transforming a haploid inducer line with (i) a first transgenic DNA sequence flanked on both sides by DNA sequences homologous to sequences upstream and downstream of the selected DNA sequence, and (ii) a second transgenic sequence that encodes a rare-cutting endonuclease, to generate a Haploid Inducer Line for Accelerated Genome Editing (HILAGE) stock line having the first and second transgenic DNA sequences stably integrated therein, wherein the transgenic DNA sequence encoding the rare-cutting endonuclease is operably linked to a promoter that is expressed in plant embryos during at least the first and second cell divisions after fertilization, and wherein the rare-cutting endonuclease is targeted to the selected DNA sequence;
(b) crossing the HILAGE stock line with a targeted line to generate an F 1 zygote comprising the stably integrated first and second transgenic DNA sequences;
(c) culturing the F 1 zygote such that (i) the rare-cutting endonuclease is expressed and cleaves chromosomal DNA of the targeted line at or near the selected DNA sequence, and the first transgenic DNA sequence is inserted at the site of cleavage, and (ii) genome elimination takes place such that chromosomes from the HILAGE stock line are eliminated, resulting in a haploid cell; and
(d) inducing chromosome doubling in the haploid cell to generate a doubled haploid plant cell comprising the first transgenic DNA sequence but not the second transgenic DNA sequence.

2. The method of claim 1 , wherein the plant cell is from maize, wheat, barley, triticale, Arabidopsis , oat, pennycress, tomato, potato, soybean, or camelina.

3. The method of claim 1 , wherein the rare-cutting endonuclease is a TALE endonuclease, a CRISPR/Cas-based nuclease, a ZFN, or a meganuclease.

4. The method of claim 1 , wherein the promoter is a cauliflower mosaic virus doubled enhanced 35S promoter, a maize ZmUb1 promoter, or a rice APX, OsCc1, EIF5, R1G1B, PGD1, Act1, or SCP1 promoter.

5. A method for generating a doubled haploid plant cell comprising a first transgenic DNA sequence inserted at or near a selected DNA sequence, said method comprising:
(a) transforming a plant cell line with (i) a first transgenic DNA sequence that is flanked on both sides by DNA sequences homologous to sequences upstream and downstream of the selected DNA sequence, and (ii) a second transgenic DNA sequence that encodes a rare-cutting endonuclease, to generate a transgenic plant cell line having the first and second transgenic DNA sequences stably integrated therein, wherein the transgenic DNA sequence encoding the rare-cutting endonuclease is operably linked to a promoter that is expressed in plant embryos during at least the first and second cell divisions after fertilization, and wherein the rare-cutting endonuclease is targeted to the selected DNA sequence;
(b) crossing the transgenic plant cell line to a haploid inducer line to generate a HILAGE stock line that is homozygous for the first and second transgenic DNA sequences, has the first and second transgenic DNA sequences stably integrated therein, and has the majority of its DNA from the haploid inducer line, where the HILAGE stock line can induce haploids upon crossing;
(c) crossing the HILAGE stock line with a targeted line to generate an F 1 zygote comprising the stably integrated first and second transgenic DNA sequences;
(d) culturing the F 1 zygote such that (i) the rare-cutting endonuclease is expressed and cleaves chromosomal DNA of the targeted line at or near the selected DNA sequence, and the first transgenic DNA sequence is inserted at the site of cleavage, and (ii) genome elimination takes place such that chromosomes from the HILAGE stock line are eliminated; and
(e) inducing chromosome doubling in the haploid cell to generate a doubled haploid plant cell comprising the first transgenic DNA sequence but not the second transgenic DNA sequence.

6. The method of claim 5 , wherein the plant cell is from maize, wheat, barley, triticale, Arabidopsis , oat, pennycress, tomato, potato, soybean, or camelina.

7. The method of claim 5 , wherein the rare-cutting endonuclease is a TALE endonuclease, a CRISPR/Cas-based nuclease, a ZFN, or a meganuclease.

8. The method of claim 5 , wherein the promoter is a cauliflower mosaic virus doubled enhanced 35S promoter, a maize ZmUb1 promoter, or a rice APX, OsCc1, EIF5, R1G1B, PGD1, Act1, or SCP1 promoter.

9. A method for generating a doubled haploid plant cell comprising a transgenic DNA sequence inserted at or near a selected DNA sequence, said method comprising:
(a) crossing a HILAGE stock line with a targeted line to generate an F 1 zygote comprising a stably integrated transgenic DNA sequence, wherein the HILAGE stock line comprises (i) a stably integrated first transgenic DNA sequence flanked on both sides by DNA sequences homologous to sequences upstream and downstream of the selected DNA sequence, and (ii) a stably integrated second transgenic DNA sequence that encodes a rare-cutting endonuclease, wherein the transgenic DNA sequence encoding the rare-cutting endonuclease is operably linked to a promoter that is expressed in plant embryos during at least the first and second cell divisions after fertilization, and wherein the rare-cutting endonuclease is targeted to the selected DNA sequence;
(b) culturing the F 1 zygote such that (i) the rare-cutting endonuclease is expressed and cleaves chromosomal DNA of the targeted line at or near the selected DNA sequence, and the first transgenic DNA sequence is inserted at the site of cleavage, and (ii) genome elimination takes place such that chromosomes from the HILAGE stock line are eliminated; and
(c) inducing chromosome doubling in the haploid cell to generate a doubled haploid plant cell comprising the first transgenic DNA sequence but not the second transgenic DNA sequence.

10. The method of claim 9 , wherein the plant cell is from maize, wheat, barley, triticale, Arabidopsis , oat, pennycress, tomato, potato, soybean, or camelina.

11. The method of claim 9 , wherein the rare-cutting endonuclease is a TALE endonuclease, a CRISPR/Cas-based nuclease, a ZFN, or a meganuclease.

12. The method of claim 9 , wherein the promoter is a cauliflower mosaic virus doubled enhanced 35S promoter, a maize ZmUb1 promoter, or a rice APX, OsCc1, EIF5, R1G1B, PGD1, Act1, or SCP1 promoter.

Assignees

• Univ Minnesota

Inventors

• Campbell Benjamin W
• Liu Junqi
• Stupar Robert M

Classifications

• C12N2310/20

  involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

• C12N9/222

  Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes · CPC title

• C12N15/8213 Primary

  Targeted insertion of genes into the plant genome by homologous recombination · CPC title

• A01H1/06

  Processes for producing mutations, e.g. treatment with chemicals or with radiation (specific mutations prepared by genetic engineering on plant cell or plant tissues C12N15/00 {; process for producing transgenic plants C12N15/82}) · CPC title

• A01H1/08

  Methods for producing changes in chromosome number · CPC title